Viewing Study NCT07424261


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-26 @ 11:37 PM
Study NCT ID: NCT07424261
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-20
First Post: 2026-02-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module